Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1483 (LINC01483) is a member of the class of long non-coding RNAs known as long intergenic non-coding RNAs (lincRNAs) [1][3][7]. LincRNAs are RNA transcripts typically longer than 200 nucleotides that do not overlap with protein-coding genes and do not encode proteins. Instead, they are involved in diverse regulatory functions, including the regulation of gene expression, chromatin structure, and transcription. While some lincRNAs are implicated in tissue-specific and disease-specific regulatory functions, no direct therapeutic relevance, disease relationship, or drug interaction has been reported for LINC01483 specifically in the scientific literature to date [1]. LINC01483 is cataloged as a lincRNA without protein-coding potential [1][3][7]. LincRNAs as a class can influence gene expression in cis or trans, participate in epigenetic regulation, and may act through RNA-RNA, RNA-DNA, and RNA-protein interactions, but individual disease or drug relevance must be established for each specific lincRNA [3][7]. For LINC01483, no such evidence is currently available.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1483 (LINC01483).